Moreover, we demonstrated that there were significant differences in YTHDF1 expression in different clinical subgroups of urogenital cancers, consistent with a previous study showing that YTHDF1 is expressed differently in KIRC at different stages (50). The gene discussed is YTHDF1; the disease is urogenital neoplasm.